Resources and Information

»Case of the Month

Mar 22 2023

Uveitic Glaucoma and Autoimmune Disease

Bud O'Leary, OD

Dr. Nora Lee Cothran discusses a patient with uveitis most likely related to his uncontrolled systemic autoimmune condition.
read more: Full Members Only

 

»Pharmacology Update

Mar 21 2023

Chart of Glaucoma Therapies

Janet Swartz, EdD

During an NGS webinar, Dr. Nora Lee Cothran presented a chart listing the various types of therapies currently available for the medical management of glaucoma.
read more: Full Members Only

 

»Glaucoma Watch

Mar 02 2023

Glaucoma Medications

Janet Swartz, EdD

Dr. Jim Thimons discusses the benefits, side effects, and clinical trials of various glaucoma medications, including Rhopressa, Rocklatan and Vyzulta.
read more: Full Members Only

 

»Case of the Month

Jan 19 2023

Glaucoma Masqueraders

Bud O'Leary, OD

Dr. Daniel Epshtein discusses cases of retinal glaucoma masqueraders and the key indicators of glaucoma or another diagnosis.
read more: Full Members Only

 

»Pharmacology Update

Dec 14 2022

Nanodropper

Janet Swartz, EdD

During an NGS webinar, a doctor asked about the Nanodropper, a device that fits onto eye drop bottles to reduce the amount of liquid dispensed.
read more

replies (3)

 

»Case of the Month

Dec 12 2022

Ganglion Cell Analysis and Visual Fields

Bud O'Leary, OD

Dr. Danica Marrelli discusses a 51-year-old patient with damage in the macula and how the information from OCT macular ganglion cell analysis and 10-2 visual fields helped to diagnose glaucoma.
read more: Full Members Only

 

»Pharmacology Update

Nov 18 2022

Floater Intervention Study

Janet Swartz, EdD

At a recent NGS webinar, there was a brief discussion of the Floater Intervention Study, which investigated the effectiveness of nutritional supplements on vitreous floaters.
read more

discuss

 

»Glaucoma Watch

Nov 14 2022

Treatment Goals in Glaucoma

Janet Swartz, EdD

Dr. Eric Schmidt discusses initial medical management of open-angle glaucoma as well as guidelines for selecting IOP targets.
read more: Full Members Only

 

 

previous